BBCvsARKGETF Comparison
VS
Virtus LifeSci Biotech Clinical Trials ETF (BBC) belongs to the Tomorrow's Treatments segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. BBC is less expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.75% for ARKG. BBC is up 27.77% year-to-date (YTD) with +$5M in YTD flows. ARKG performs better with 55.92% YTD performance, and +$33M in YTD flows. Run a side-by-side ETF comparison of BBC and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBC vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBC ARKG | -5.78%+2.07% | +17.22%+35.35% | +27.77%+55.92% | +102.82%+73.72% | +137.50%+44.39% | +6.45%-43.98% |
| Flows | BBC ARKG | -+$57M | +$83K+$127M | +$5M+$33M | +$12M+$51M | +$16M-$523M | +$8M-$2.24B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBC ARKG | +33.39%+42.98% | +36.22%+43.87% | +37.22%+43.91% | +39.64%+46.35% |
| Max drawdown | BBC ARKG | -11.65%-13.89% | -14.64%-27.52% | -54.25%-46.41% | -70.43%-78.04% |
| Max drawdown duration | BBC ARKG | 23d32d | 60d126d | 340d882d | 1666d1818d |
Trading data
BBC | ARKG | |
Last sale 9/14/2026 at 1:30 PM | $49.94 | $46.80 |
| Previous close 09/11/2026 | $49.39 | $45.56 |
| Consolidated volume 09/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexBBC | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/14/2026 at 1:30 PM
Live
Closed
BBC | ARKG | |
|---|---|---|
| Last price | $49.94 | $46.80 |
| 1D performance | +1.12% | +2.72% |
| AuM | $46.95 M | $1.83 B |
| E/R | 0.65% | 0.75% |
Characteristics
BBC | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Ark Investment |
| Benchmark | LifeSci Biotechnology Clinical Trials Index | - |
| N° of holdings | 127 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBC
USA
86.49%
Other
13.51%
ARKG
USA
88.43%
Other
11.57%
Sectors
BBC
Healthcare
95.06%
Other
4.94%
ARKG
Healthcare
97.99%
Other
2.01%
Advertisement
Diversification
BBC
Total weight of top 15 holdings out of 15
15.32%
ARKG
Total weight of top 15 holdings out of 15
75.55%
Top 15 holdings
Data as of July 31, 2026
BBC
First Tracks Biotherapeutics, Inc.
1.57%
Monopar Therapeutics, Inc.
1.22%
MBX Biosciences, Inc.
1.14%
Zenas BioPharma, Inc.
1.09%
Xencor, Inc.
1.06%
Apogee Therapeutics, Inc.
1.00%
REGENXBIO, Inc.
0.96%
Oric Pharmaceuticals, Inc.
0.96%
Dyne Therapeutics, Inc.
0.93%
uniQure NV
0.91%
SELLAS Life Sciences Group, Inc.
0.91%
Nurix Therapeutics, Inc.
0.91%
Vor Biopharma, Inc.
0.89%
Erasca, Inc.
0.89%
Amylyx Pharmaceuticals, Inc.
0.88%
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
Frequently asked questions about BBC and ARKG
How have the BBC and ARKG ETFs performed in 2026?
As of September 11, 2026, BBC is up 27.77% year-to-date (YTD), while ARKG has returned 55.92%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: BBC or ARKG?
Year-to-date, the BBC ETF saw +$5M in flows, compared to +$33M for ARKG.
Which ETF is more volatile: BBC or ARKG?
Over the past year, BBC had a volatility of 36.22%, while ARKG experienced 43.87%.
Which ETF is bigger: BBC or ARKG?
As of September 11, 2026, BBC holds $46.95 M in assets under management (AUM), while ARKG manages $1.83 B.
What sectors do the BBC and ARKG ETFs invest in?
BBC leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the BBC ETF and ARKG ETF?
BBC top holdings include First Tracks Biotherapeutics, Inc., Monopar Therapeutics, Inc. and MBX Biosciences, Inc.. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..
Which ETF is more diversified: BBC or ARKG?
BBC holds 127 securities with 15.32% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 75.55%.
Latest news about BBC & ARKG
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
BBC
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
